Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Other Accumulated Expenses: 2009-2016

Historic Other Accumulated Expenses for Fresenius Medical Care AG (FMS) over the last 14 years, with Q4 2024 value amounting to $5.1 billion.

  • Fresenius Medical Care AG's Other Accumulated Expenses fell 1170.96% to $5.1 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $5.1 billion, marking a year-over-year decrease of 1170.96%. This contributed to the annual value of $5.1 billion for FY2024, which is 1057.42% down from last year.
  • According to the latest figures from Q4 2024, Fresenius Medical Care AG's Other Accumulated Expenses is $5.1 billion, which was down 1170.96% from $5.8 billion recorded in Q4 2023.
  • Fresenius Medical Care AG's Other Accumulated Expenses' 5-year high stood at $5.8 billion during Q4 2023, with a 5-year trough of $46.72 in Q3 2020.
  • In the last 5 years, Fresenius Medical Care AG's Other Accumulated Expenses had a median value of $52.7 million in 2020 and averaged $1.8 billion.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first plummeted by 7554.13% in 2021, then plummeted by 1170.96% in 2024.
  • Fresenius Medical Care AG's Other Accumulated Expenses (Quarter) stood at $46.72 in 2020, then skyrocketed by 1281.52% to $645.49 in 2021, then surged by 16329524.25% to $105.4 million in 2022, then skyrocketed by 5361.05% to $5.8 billion in 2023, then fell by 11.71% to $5.1 billion in 2024.
  • Its Other Accumulated Expenses was $5.1 billion in Q4 2024, compared to $5.8 billion in Q4 2023 and $105.4 million in Q3 2022.